HPV 16 POSITIVE OROPHARYNGEAL TUMORS (OPC)

Clinical trials for HPV 16 POSITIVE OROPHARYNGEAL TUMORS (OPC) explained in plain language.

Never miss a new study

Get alerted when new HPV 16 POSITIVE OROPHARYNGEAL TUMORS (OPC) trials appear

Sign up with your email to follow new studies for HPV 16 POSITIVE OROPHARYNGEAL TUMORS (OPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New drug combo aims to spare cancer patients from disfiguring surgery

Disease control Recruiting now

This study is testing a new approach for people with advanced head and neck cancer. The goal is to see if giving a combination of chemotherapy and immunotherapy *before* surgery can shrink tumors enough to allow surgeons to perform less extensive operations. This could help prese…

Matched conditions: HPV 16 POSITIVE OROPHARYNGEAL TUMORS (OPC)

Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

HPV 16 POSITIVE OROPHARYNGEAL TUMORS (OPC)

Get alerted when new HPV 16 POSITIVE OROPHARYNGEAL TUMORS (OPC) trials appear

New drug combo aims to spare cancer patients from disfiguring surgery